Jason Lin, Chairman of United Orthopedic, expressed confidence in the sustained strength of the company’s core direct-operated markets. With promising performance expected from the UK in Europe, high growth in Japan’s established market, and the upcoming shipment of co-branded products with Kyocera in May, the company anticipates a stronger growth trajectory than in the past two years. Additionally, the benefits from China’s centralized procurement are expected to amplify further. The company reported a 21.7% year-on-year revenue growth in the first quarter, with steady upward momentum across markets, aiming to achieve a 20% increase in annual revenue.
Read more
